Mountain View, CA -— Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., today announced that it has entered into an exclusive agreement with Ludwig Cancer Research for rights to the Smart-seq2 method for single-cell RNA-seq, which was developed in Rickard Sandberg’s laboratory at Ludwig Stockholm. As a result of this agreement, Clontech will […]
MENLO PARK, Calif. — Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio® RS II Sequencing System, today announced that the company has launched a Certified Service Provider (CSP) program and added new informatics partners to meet the increasing demand for Single Molecule, Real-Time (SMRT®) Sequencing and data analysis worldwide. The PacBio CSP program […]
ST. LOUIS — Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading Life Science and Technology company, announced today it signed an exclusive global distribution agreement with Roche (SIX: RO, ROG; OTCQX: RHHBY). The agreement pairs Roche’shigh-quality Biochemical Reagents product portfolio with the industry-leading eCommerce and supply chain capabilities of Sigma-Aldrich. Under the agreement, Sigma-Aldrich will employ its […]
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today a global distribution agreement for its Biochemical Reagents product portfolio with Sigma-Aldrich Corporation (NASDAQ: SIAL). These products include kits and enzymes for cellular analysis, proteomics and conventional PCR applications. Under the terms of the agreement, Sigma-Aldrich will acquire exclusive rights for worldwide distribution of these products. Roche […]
HILDEN, Germany, and REDWOOD CITY, California -– QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced a commercial agreement with GATC Biotech to provide GATC clients full access to QIAGEN’s Ingenuity® Variant AnalysisTM solution for analysis and interpretation of genetic data. GATC is one of Europe’s leading providers of DNA and RNA sequencing services […]
ANDOVER, Mass. — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of technologies that enable advanced processes and improve productivity, announces the acquisition of Precisive, LLC, for $13 million in an all-cash transaction that closed yesterday. Precisive is an innovative developer of optical analyzers based on Tunable Filter Spectroscopy (TFS) which provide real-time gas analysis […]
Madrid, Spain and Heidelberg, Germany -– SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced a distribution agreement with SOPACHEM for the commercialization of the TruePrime™ product family developed by SYGNIS and designed for whole genome amplification (WGA) in Belgium. Under the terms of the agreement, SOPACHEM will promote, market, sell and support TruePrime™ […]
Boston, MA -– Cartagenia, leader in providing clinical genetics and pathology labs with variant assessment & reporting support software, today announced a partnership with Lexington, MA-based N-of-One, an industry-leading provider of patient-specific Clinical Interpretation for molecular profiles at the disease, gene and variant level. With the availability of N-of-One’s services from within the Bench Lab […]
Darmstadt, Germany — Merck, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials, successfully placed a U.S. bond via its U.S. subsidiary EMD Finance LLC. The oversubscribed placement is an important element of the financing of the proposed acquisition of the life science company Sigma-Aldrich, which Merck announced […]
Basel, Switzerland — Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced a collaboration with Bayer Pharma AG to develop a new workflow management system to support the automation of the Cell Line Development (CLD) process for mammalian cells used to produce biopharmaceuticals. Genedata’s new CLD Data […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
